Novo Nordisk (NOVOB DC) confirms that it received an untitled letter from the FDA concerning a TV commercial for the WeGovy pill
Importance
Level 1
#NOVO NORDISK A/S#NOVOB.DC#FDA#EU SESSION#US SESSION#EUROPEAN EQUITIES
© 2026 Newsquawk. All rights reserved.